Literature DB >> 12110609

P2Y(1) and P2Y(2) receptors are coupled to the NO/cGMP pathway to vasodilate the rat arterial mesenteric bed.

Sonja Buvinic1, René Briones, J Pablo Huidobro-Toro.   

Abstract

1. To assess the role of nucleotide receptors in endothelial-smooth muscle signalling, changes in perfusion pressure of the rat arterial mesenteric bed, the luminal output of nitric oxide (NO) and guanosine 3',5' cyclic monophosphate (cGMP) accumulation were measured after the perfusion of nucleotides. 2. The rank order of potency of ATP and analogues in causing relaxation of precontracted mesenteries was: 2-MeSADP=2-MeSATP>ADP>ATP=UDP=UTP>adenosine. The vasodilatation was coupled to a concentration-dependent rise in NO and cGMP production. MRS 2179 selectively blocked the 2-MeSATP-induced vasodilatation, the NO surge and the cGMP accumulation, but not the UTP or ATP vasorelaxation. 3. mRNA encoding for P2Y(1), P2Y(2) and P2Y(6) receptors, but not the P2Y(4) receptor, was detected in intact mesenteries by RT-PCR. After endothelium removal, only P2Y(6) mRNA was found. 4. Endothelium removal or blockade of NO synthase obliterated the nucleotides-induced dilatation, the NO rise and cGMP accumulation. Furthermore, 2-MeSATP, ATP, UTP and UDP contracted endothelium-denuded mesenteries, revealing additional muscular P2Y and P2X receptors. 5. Blockade of soluble guanylyl cyclase reduced the 2-MeSATP and UTP-induced vasodilatation and the accumulation of cGMP without interfering with NO production. 6. Blockade of phosphodiesterases with IBMX increased 15-20 fold the 2-MeSATP and UTP-induced rise in cGMP; sildenafil only doubled the cGMP accumulation. A linear correlation between the rise in NO and cGMP was found. 7. Endothelial P2Y(1) and P2Y(2) receptors coupled to the NO/cGMP cascade suggest that extracellular nucleotides are involved in endothelial-smooth muscle signalling. Additional muscular P2Y and P2X receptors highlight the physiology of nucleotides in vascular regulation. British Journal of Pharmacology (2002) 136, 847-856

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12110609      PMCID: PMC1573418          DOI: 10.1038/sj.bjp.0704789

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  50 in total

1.  Effects of IBMX on norepinephrine-induced vasoconstriction in small mesenteric arteries.

Authors:  M S Taylor; H Gao; J D Gardner; J N Benoit
Journal:  Am J Physiol       Date:  1999-04

Review 2.  Guanylyl cyclases and signaling by cyclic GMP.

Authors:  K A Lucas; G M Pitari; S Kazerounian; I Ruiz-Stewart; J Park; S Schulz; K P Chepenik; S A Waldman
Journal:  Pharmacol Rev       Date:  2000-09       Impact factor: 25.468

Review 3.  Nitric oxide in the vasculature: physiology and pathophysiology.

Authors:  S Moncada
Journal:  Ann N Y Acad Sci       Date:  1997-04-15       Impact factor: 5.691

4.  Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes.

Authors:  S A Ballard; C J Gingell; K Tang; L A Turner; M E Price; A M Naylor
Journal:  J Urol       Date:  1998-06       Impact factor: 7.450

5.  Clonidine-induced nitric oxide-dependent vasorelaxation mediated by endothelial alpha(2)-adrenoceptor activation.

Authors:  X F Figueroa; M I Poblete; M P Boric; V E Mendizábal; E Adler-Graschinsky; J P Huidobro-Toro
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

Review 6.  Molecular mechanism of cGMP-mediated smooth muscle relaxation.

Authors:  J A Carvajal; A M Germain; J P Huidobro-Toro; C P Weiner
Journal:  J Cell Physiol       Date:  2000-09       Impact factor: 6.384

7.  Characterization of P2 receptors for purine and pyrimidine nucleotides in human placental cotyledons.

Authors:  V Ralevic; S Burrell; J Kingdom; G Burnstock
Journal:  Br J Pharmacol       Date:  1997-07       Impact factor: 8.739

8.  Models of the diffusional spread of nitric oxide: implications for neural nitric oxide signalling and its pharmacological properties.

Authors:  J Wood; J Garthwaite
Journal:  Neuropharmacology       Date:  1994-11       Impact factor: 5.250

9.  Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR.

Authors:  D Erlinge; M Hou; T E Webb; E A Barnard; S Möller
Journal:  Biochem Biophys Res Commun       Date:  1998-07-30       Impact factor: 3.575

10.  Vasoconstrictor and vasodilator responses to various agonists in the rat perfused mesenteric arterial bed: selective inhibition by PPADS of contractions mediated via P2x-purinoceptors.

Authors:  U Windscheif; V Ralevic; H G Bäumert; E Mutschler; G Lambrecht; G Burnstock
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

View more
  43 in total

1.  Functional contribution of P2Y1 receptors to the control of coronary blood flow.

Authors:  Shawn B Bender; Zachary C Berwick; M Harold Laughlin; Johnathan D Tune
Journal:  J Appl Physiol (1985)       Date:  2011-09-22

2.  Expression of pannexin isoforms in the systemic murine arterial network.

Authors:  Alexander W Lohman; Marie Billaud; Adam C Straub; Scott R Johnstone; Angela K Best; Monica Lee; Kevin Barr; Silvia Penuela; Dale W Laird; Brant E Isakson
Journal:  J Vasc Res       Date:  2012-06-26       Impact factor: 1.934

3.  Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aorta.

Authors:  Pieter-Jan D F Guns; András Korda; Herta M Crauwels; Tim Van Assche; Bernard Robaye; Jean-Marie Boeynaems; Hidde Bult
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

Review 4.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

5.  Biomechanical Forces and Oxidative Stress: Implications for Pulmonary Vascular Disease.

Authors:  Evgeny A Zemskov; Qing Lu; Wojciech Ornatowski; Christina N Klinger; Ankit A Desai; Emin Maltepe; Jason X-J Yuan; Ting Wang; Jeffrey R Fineman; Stephen M Black
Journal:  Antioxid Redox Signal       Date:  2019-03-19       Impact factor: 8.401

6.  Endothelium-dependent relaxation evoked by ATP and UTP in the aorta of P2Y2-deficient mice.

Authors:  Pieter-Jan D F Guns; Tim Van Assche; Paul Fransen; Bernard Robaye; Jean-Marie Boeynaems; Hidde Bult
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

7.  Alterations in perivascular innervation function in mesenteric arteries from offspring of diabetic rats.

Authors:  D B de Queiroz; E Sastre; L Caracuel; M Callejo; F E Xavier; J Blanco-Rivero; G Balfagón
Journal:  Br J Pharmacol       Date:  2015-08-14       Impact factor: 8.739

8.  Spreading dilatation to luminal perfusion of ATP and UTP in rat isolated small mesenteric arteries.

Authors:  Polly Winter; Kim A Dora
Journal:  J Physiol       Date:  2007-05-03       Impact factor: 5.182

9.  ADP signaling in vascular endothelial cells: ADP-dependent activation of the endothelial isoform of nitric-oxide synthase requires the expression but not the kinase activity of AMP-activated protein kinase.

Authors:  Connie Ng Hess; Ruqin Kou; Rosalyn P Johnson; Gordon K Li; Thomas Michel
Journal:  J Biol Chem       Date:  2009-09-25       Impact factor: 5.157

10.  Mechanism of purinergic activation of endothelial nitric oxide synthase in endothelial cells.

Authors:  Cleide Gonçalves da Silva; Anke Specht; Barbara Wegiel; Christiane Ferran; Elzbieta Kaczmarek
Journal:  Circulation       Date:  2009-02-02       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.